Achilles Therapeutics plc
Achilles Therapeutics plc is grouped at the issuer level across 1 linked ticker lifecycle, combining public listing, delisting, source, and shareholder outcome records from the archive.
Lifecycle Map
Issuer enters the archive
Mar 1, 2021Achilles Therapeutics plc is represented as an issuer-level entity with 1 linked public-market ticker lifecycle.
Delisting event
Mar 11, 2025Removed from listing - SEC Form 25 filed.
SourceACHL stopped trading
Mar 11, 2025ACHL is linked to Achilles Therapeutics plc and ended with final status "delisted".
Source
Entity Graph
Achilles Therapeutics plcissuedACHL
ACHLlisted onNASDAQ
ACHLresulted inunknown
Source-Backed Claims
- Achilles Therapeutics plc filed a Form 25 on 2025-03-11.Form 25
- The filing was made to notify the removal of Achilles Therapeutics plc from listing and/or registration under Section 12(b) of the Securities Exchange Act of 1934.Form 25
- The class of securities removed from listing was American Depositary Shares, each representing one ordinary share with a nominal value of £0.001 per share.Form 25
- Achilles Therapeutics plc confirmed it has reasonable grounds to believe it meets all requirements for filing Form 25.Form 25
- The notification was signed by Robert Coutts, Chief Financial Officer of Achilles Therapeutics plc.Form 25
- The address of Achilles Therapeutics plc is 3rd Floor, 1 Ashley Road, Altrincham, Cheshire WA14 2DT, United Kingdom.Form 25
- Achilles Therapeutics plc's telephone number is +44 (0)20 8154 4600.Form 25
Associated Tickers
Public-market security lifecycles tied to this issuer record.